Emergence of drug resistance is associated with an increased risk of death among patients first starting HAART.
<h4>Background</h4>The impact of the emergence of drug-resistance mutations on mortality is not well characterized in antiretroviral-naïve patients first starting highly active antiretroviral therapy (HAART). Patients may be able to sustain immunologic function with resistant virus, and...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2006-09-01
|
Series: | PLoS Medicine |
Online Access: | https://doi.org/10.1371/journal.pmed.0030356 |